Autocrine stimulation by erythropoietin and autonomous growth of human erythroid leukemic cells in vitro
- PMID: 1653276
- PMCID: PMC295463
- DOI: 10.1172/JCI115378
Autocrine stimulation by erythropoietin and autonomous growth of human erythroid leukemic cells in vitro
Abstract
Autonomous colony formation is a frequent event in erythroleukemia. In 13 cases of early erythroid leukemias, we investigated whether erythropoietin (Epo) autocrine stimulation was responsible for the growth factor autonomy. Epo transcripts were detected by Northern blotting in cells from one patient. These cells also expressed an Epo receptor (1,000 receptors per cell) with a 420-pM affinity and Epo was detected in the supernatant of cultured cells. In 8 of the 13 cases, Epo transcripts were revealed by the polymerase chain reaction ranging from 0.5 to 500 copies per cell. In situ hybridization proved that these Epo transcripts were present in the blast cells. No Epo gene abnormalities were detected by Southern blotting. In two cases, leukemic cells were grown in the presence of Epo-neutralizing antibodies or Epo antisense oligomers. In one case, the antibody significantly reduced autonomous growth. In contrast, the antibody had no effect in the second case in which blast cells transcribed the Epo gene at a low level. However, Epo antisense oligomers partially inhibited autonomous growth. This inhibition was reversed by addition of exogenous Epo. Overall, these results suggest that an extracellular or intracellular autocrine Epo stimulation occurs in some cases of erythroid malignancies.
Similar articles
-
Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation.EMBO J. 1996 Aug 15;15(16):4174-81. EMBO J. 1996. PMID: 8861946 Free PMC article.
-
Evidence for internal autocrine regulation of growth in acute myeloblastic leukemia cells.Exp Hematol. 1994 Jul;22(7):593-8. Exp Hematol. 1994. PMID: 7516889
-
Induction of the receptor for erythropoietin in murine erythroleukemia cells after dimethyl sulfoxide treatment.Cancer Res. 1988 Apr 1;48(7):1818-22. Cancer Res. 1988. PMID: 2832053
-
[Erythropoietin].Tanpakushitsu Kakusan Koso. 1992 Aug;37(11 Suppl):1713-22. Tanpakushitsu Kakusan Koso. 1992. PMID: 1410455 Review. Japanese. No abstract available.
-
[Human erythropoietin and its cellular targets].Rev Fr Transfus Hemobiol. 1991 Jan;34(1):49-62. doi: 10.1016/s1140-4639(05)80088-7. Rev Fr Transfus Hemobiol. 1991. PMID: 1849717 Review. French. No abstract available.
Cited by
-
Induction of erythropoietin increases the cell proliferation rate in a hypoxia-inducible factor-1-dependent and -independent manner in renal cell carcinoma cell lines.Oncol Lett. 2013 Jun;5(6):1765-1770. doi: 10.3892/ol.2013.1283. Epub 2013 Apr 3. Oncol Lett. 2013. PMID: 23833638 Free PMC article.
-
Erythroid progenitors differentiate and mature in response to endogenous erythropoietin.J Clin Invest. 2000 Jul;106(2):263-70. doi: 10.1172/JCI9361. J Clin Invest. 2000. PMID: 10903342 Free PMC article.
-
Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.Am J Pathol. 2003 Jun;162(6):1789-806. doi: 10.1016/S0002-9440(10)64314-3. Am J Pathol. 2003. PMID: 12759237 Free PMC article.
-
Alteration of L-Dopa decarboxylase expression in SARS-CoV-2 infection and its association with the interferon-inducible ACE2 isoform.PLoS One. 2021 Jun 29;16(6):e0253458. doi: 10.1371/journal.pone.0253458. eCollection 2021. PLoS One. 2021. PMID: 34185793 Free PMC article.
-
Constitutive activation of Stat1 and Stat3 in primary erythroleukemia cells.Int J Hematol. 2002 Jan;75(1):51-4. doi: 10.1007/BF02981979. Int J Hematol. 2002. PMID: 11843291
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials